News
Taxing imports to the US could spell major consequences for health care prices, innovation, and access, as a great amount of ...
Indian generic and formulation pharmaceutical (pharma) companies are contending with tariff-related challenges and subdued ...
1d
Khaleej Times on MSNUAE emerges as global pharmaceutical hub with market poised to hit $8 billionThe UAE's pharmaceutical sector is witnessing robust growth, with the market valued at $4.15 billion and projected to double ...
Pfizer's abnormally high yield seems more a symptom of all this negative sentiment than a red flag about the dividend's sustainability. Management just raised the quarterly dividend in December, and ...
13don MSN
Traditionally, stock market corrections have been the perfect time for long-term-minded investors with ample cash on hand to ...
6d
Zacks Investment Research on MSNHere's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
The Pharmaceutical Emulsifiers Market has seen substantial growth in recent years, driven by the increasing demand for advanced drug delivery systems and formulations that are more efficient and ...
Organoids are made to model human organs and are promising for research and therapy, but there are limitations in their ...
The event "Healthcare Shift" was held today in Rome at the American Studies Center. Among the topics discussed were the ...
Looking at cash flow, BioMarin Pharmaceutical is expected to report cash flow growth of 83.6% this year; BMRN has generated cash flow growth of 40.1% over the past three to five years. With solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results